Upstream Bio will use its IPO haul to continue clinical testing of verekitug, which it contends could be a better treatment option for severe asthma compared to a commercialized Amgen and ...

Katie Adams is a senior reporter for MedCity News covering providers and healthcare technology. Previously, she worked as a healthcare technology editor at Becker’s Hospital Review. Her ...

Erin Dietsche covers the hospitals and health IT beats for MedCity News. She previously worked as a writer/reporter for Becker's Hospital Review, where she covered everything from payer issues to ...